Cotización ProShares Ultra NASDAQ B... - BIB

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

51.41

Postura de Compra

47.86

Postura de Venta

60.60

Volume Operado de la Acción

7,001

49.49 Rango del Día 52.4113

47.195 Rango de 52 semanas 69.56

Capitalización de Mercado [m]

80.971M

Precio Anterior

50.50

Precio de Apertura

49.49

Hora

53.98

Última hora de negociación

Volumen financiero

US$ 360,318

Precio Promedio Ponderado

51.4667

Volumen promedio (3 m)

11,733

Acciones en circulación

1,575,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

14.83

Beneficio por acción (BPA)

3.47

turnover

1.26M

Beneficio neto

5.47M

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment object... The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. Mostrar más

Sector

Mgmt Invt Offices, Open-end

Industria

Mgmt Invt Offices, Open-end

Sede

Wilmington, Delaware, USA

Fundado

ProShares Ultra NASDAQ Biotechnology is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker BIB. The last closing price for ProShares Ultra NASDAQ B... was US$50.50. Over the last year, ProShares Ultra NASDAQ B... shares have traded in a share price range of US$ 47.195 to US$ 69.56.

ProShares Ultra NASDAQ B... currently has 1,575,000 shares in issue. The market capitalisation of ProShares Ultra NASDAQ B... is US$79.54 million. ProShares Ultra NASDAQ B... has a price to earnings ratio (PE ratio) of 14.83.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-3.2	-5.8597326497	54.61	56.19	49.5	12511	53.27393634	SP
4	-4.2126	-7.57354025162	55.6226	60.1	49.5	9657	56.63516985	SP
12	-11.76	-18.6164318506	63.17	68	49.5	11733	60.44690157	SP
26	-4.9	-8.70182916001	56.31	69.56	49.5	12333	62.75427267	SP
52	-1.86	-3.49164633002	53.27	69.56	47.195	22891	58.5491449	SP
156	-33.09	-39.1597633136	84.5	85.1799	38.42	26734	56.41138766	SP
260	-11.07	-17.7176696543	62.48	113.06	35.495	77185	70.929894	SP

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M